Tissue Regenix Group plc (AIM:TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 31.50
-0.50 (-1.56%)
Jun 5, 2025, 4:35 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 22.44 million as of June 5, 2025. Its market cap has decreased by -48.60% in one year.
Market Cap
22.44M
Enterprise Value
27.43M
Revenue
25.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.50
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 22.44M, a decrease of -45.27%. That is a compound annual growth rate of -3.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 164.96B |
| GSK plc | 61.51B |
| Haleon | 36.46B |
| Smith & Nephew | 9.42B |
| ConvaTec Group | 5.94B |
| Hikma Pharmaceuticals | 4.73B |
| HUTCHMED (China) | 1.86B |
| Genus | 1.31B |